On May, 3 The EPS for Teleflex Incorporated (TFX) Expected At $1.94

April 16, 2018 - By Leslie Harms

Teleflex Incorporated (NYSE:TFX) Corporate Logo
Big Money Sentiment increased to 1.13 in 2017 Q4. It has change of 0.03, from 2017Q3’s 1.1. The ratio is positive due to Teleflex Incorporated positioning: 19 sold and 132 reduced. 62 funds bought holdings and 108 increased holdings. Investors holded 39.29 million in 2017Q3 but now own 39.40 million shares or 0.28% more.
Sg Americas Lc reported 21,173 shs. Federated Pa has 93,433 shs for 0.07% of their capital. Gotham Asset Ltd Limited Liability Company owns 0.08% invested in Teleflex Incorporated (NYSE:TFX) for 22,086 shs. Dekabank Deutsche Girozentrale has 3,396 shs for 0.01% of their capital. 4,137 are held by Ls Investment Advsr. Keybank Natl Association Oh has 0% invested in Teleflex Incorporated (NYSE:TFX). Fayerweather Charles reported 1,200 shs. Lombard Odier Asset (Switzerland) has 0.15% invested in Teleflex Incorporated (NYSE:TFX). The Illinois-based Guggenheim Cap Limited Liability Company has invested 0.03% in Teleflex Incorporated (NYSE:TFX). Td Asset Management has invested 0.05% in Teleflex Incorporated (NYSE:TFX). British Columbia Investment Management accumulated 16,543 shs or 0.03% of the stock. Moreover, Stonebridge Mngmt has 0.12% invested in Teleflex Incorporated (NYSE:TFX). Winslow Evans & Crocker Inc holds 84 shs or 0.01% of its capital. 58,367 were accumulated by Eaton Vance Management. The Japan-based Sumitomo Mitsui Hldgs has invested 0.04% in Teleflex Incorporated (NYSE:TFX).

Teleflex Incorporated registered $7.36 million net activity with 0 insider purchases and 11 selling transactions since January 2, 2018. Klasko Stephen K. M.D. sold $55,288 worth of Teleflex Incorporated (NYSE:TFX) or 200 shs on Thursday, February 1. Deren John sold $347,449 worth of stock. On Monday, April 2 a trade for 9,331 shs valued at $2.35 million was made by SMITH BENSON.

Teleflex Incorporated (NYSE:TFX)’s quarterly earnings will be reported On May, 3., according to Faxor. Last year’s earnings per share was $1.8, while now analysts expect change of 7.78 % up from current $1.94 earnings per share. If earnings per share of $1.94 is reported the profit of TFX could be $88.14 million giving it 33.72 P/E. -20.49 % negative EPS growth is what Wall Street’s predicts after $2.44 reported EPS last quarter. TFX reached $261.68 on during the last trading session after $4.16 change.Teleflex Incorporated has volume of 68,558 shares. Since April 16, 2017 TFX has risen 32.04% and is uptrending. The stock outperformed the S&P 500 by 20.49%.

Teleflex Incorporated (NYSE:TFX) Ratings Coverage

Total analysts of 10 have positions in Teleflex Inc (NYSE:TFX) as follows: 6 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 60%. Since November 2, 2017 according to StockzIntelligence Inc Teleflex Inc has 12 analyst reports. On Friday, February 23 Leerink Swann maintained Teleflex Incorporated (NYSE:TFX) with “Outperform” rating. On Tuesday, November 14 the rating was downgraded by Deutsche Bank to “Hold”. On Friday, November 3 Needham maintained Teleflex Incorporated (NYSE:TFX) rating. Needham has “Buy” rating and $285.0 target. On Friday, November 10 the firm has “Buy” rating by Piper Jaffray given. The company rating was maintained by Jefferies on Thursday, February 22. On Thursday, November 2 the rating was maintained by Jefferies with “Buy”. The stock rating was maintained by Stephens with “Buy” on Wednesday, January 17. On Thursday, November 16 KeyBanc Capital Markets maintained Teleflex Incorporated (NYSE:TFX) with “Hold” rating. On Tuesday, January 30 the stock of Teleflex Incorporated (NYSE:TFX) earned “Buy” rating by Leerink Swann. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, November 3.

Teleflex Incorporated designs, develops, makes, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.The firm is valued at $11.89 billion. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand.The P/E ratio is 80. The firm also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands.

Teleflex Incorporated (NYSE:TFX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: